Advanced Accelerator Applications

Advanced Accelerator Applications company information, Employees & Contact Information

We are your partner of choice in Europe for precision diagnostic solutions for positron emission tomography (PET) imaging – a cornerstone of personalized nuclear medicine. Our core mission is to develop, manufacture, test, and timely supply radiopharmaceutical products for patients in need, with a primary focus on oncology, while expanding our network and expertise into other disease areas, such as neurology, as we continue to unlock the potential of molecular imaging in nuclear medicine.

Company Details

Employees
719
Address
20 Rue Diesel, Saint Genis Pouilly,01630,france
Phone
33 4 50 99 30 70
Email
ph****@****cap.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
adacap.com
HQ
Saint Genis Pouilly
Looking for a particular Advanced Accelerator Applications employee's phone or email?

Advanced Accelerator Applications Questions

News

Joining forces for global impact: expanding radiopharmaceutical access - Siemens Healthineers

Joining forces for global impact: expanding radiopharmaceutical access Siemens Healthineers

AAA Acquires GE Healthcare's FDG-PET Radiopharmaceutical Business in Italy - ACCESS Newswire

AAA Acquires GE Healthcare's FDG-PET Radiopharmaceutical Business in Italy ACCESS Newswire

Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer - GlobeNewswire

Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer GlobeNewswire

Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period - Novartis

Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period Novartis

Advanced Accelerator Applications to Build Targeted Radioligand Therapy Production Facility in Indianapolis - PR Newswire

Advanced Accelerator Applications to Build Targeted Radioligand Therapy Production Facility in Indianapolis PR Newswire

AAA announces Ph3 NETTER-2 study with Lutathera as 1st Line in advanced GEP-NET - EurekAlert!

AAA announces Ph3 NETTER-2 study with Lutathera as 1st Line in advanced GEP-NET EurekAlert!

Advanced Accelerator Applications Launches “Hope Is Like Air” Campaign in support of NET Cancer Day - MultiVu

Advanced Accelerator Applications Launches “Hope Is Like Air” Campaign in support of NET Cancer Day MultiVu

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer - News-Medical

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer News-Medical

Novartis’ Bet Pays Off as Advanced Accelerator Applications Wins FDA Nod for Lutathera - BioSpace

Novartis’ Bet Pays Off as Advanced Accelerator Applications Wins FDA Nod for Lutathera BioSpace

Advanced Accelerator Applications Receives FDA Approval for Lutathera® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors - Novartis

Advanced Accelerator Applications Receives FDA Approval for Lutathera® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors Novartis

Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging - Siemens Healthineers

Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging Siemens Healthineers

Advanced Accelerator Applications Announces Health Canada Approval of NETSPOT® Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours - PR Newswire Canada

Advanced Accelerator Applications Announces Health Canada Approval of NETSPOT® Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours PR Newswire Canada

AAA receives positive CHMP opinion for LysaKare - EurekAlert!

AAA receives positive CHMP opinion for LysaKare EurekAlert!

Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by Novartis - GlobeNewswire

Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by Novartis GlobeNewswire

Radiopharmaceutical cancer treatment Lutathera® now available to Ontario patients with midgut neuroendocrine tumours (NETs) - PR Newswire Canada

Radiopharmaceutical cancer treatment Lutathera® now available to Ontario patients with midgut neuroendocrine tumours (NETs) PR Newswire Canada

Novartis completes subsequent offering period of the tender offer for Advanced Accelerator Applications S.A. - Novartis

Novartis completes subsequent offering period of the tender offer for Advanced Accelerator Applications S.A. Novartis

PLUVICTO™ receives positive recommendations from CADTH and INESSS for progressive PSMA-positive metastatic castration-resistant prostate cancer - PR Newswire Canada

PLUVICTO™ receives positive recommendations from CADTH and INESSS for progressive PSMA-positive metastatic castration-resistant prostate cancer PR Newswire Canada

Advanced Accelerator Applications Acquires the IDB Group - GlobeNewswire

Advanced Accelerator Applications Acquires the IDB Group GlobeNewswire

Health Canada approves PLUVICTO™ as first targeted radioligand therapy for progressive PSMA‑positive metastatic castration-resistant prostate cancer - PR Newswire Canada

Health Canada approves PLUVICTO™ as first targeted radioligand therapy for progressive PSMA‑positive metastatic castration-resistant prostate cancer PR Newswire Canada

Radiopharmaceutical Lutathera® now reimbursed in Quebec for cancer patients with advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs) - PR Newswire Canada

Radiopharmaceutical Lutathera® now reimbursed in Quebec for cancer patients with advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs) PR Newswire Canada

Top Advanced Accelerator Applications Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant